An early intervention developed for caregivers of patients with serious illnesses or injuries will be tested by researchers at The University of Texas Health Science Center at Houston (UTHealth).
- Cardiothoracic & Vascular Surgery
- Children's Health Stories
- Coronavirus Español
- COVID-19 Patient Resources
- Ear, Nose, and Throat Stories
- Heart Care
- In the Media
- In the Media Español
- Patient Stories
- Pediatric Surgery
- UTHealth COVID-19 Research
- UTHealth Research
- Women's Health Stories
First Houston post-coronavirus clinic part of new UTHealth COVID-19 Center of Excellence
Bringing together expertise and access to the best clinical care, research trials, discovery science, and public health knowledge, The University of Texas Health Science Center at Houston (UTHealth) has established the UTHealth COVID-19 Center of Excellence.
Researchers studying new nonsurgical treatment for chronic sinusitis
Researchers at The University of Texas Health Science Center at Houston (UTHealth) are investigating the efficacy and safety of an intranasal treatment for adults with chronic sinusitis with or without nasal polyps.
Clinical trial to assess rehabilitation treatment for infants and toddlers after stroke
In the first of its kind for the tiniest stroke survivors, researchers at The University of Texas Health Science Center at Houston (UTHealth) will lead a stroke rehabilitation clinical trial in the state of Texas through a multi-institutional NIH StrokeNet initiative.
- Placenta accreta month: Novel approach to life-threatening pregnancy condition allows woman to have “miracle child” after loss Margarita Saavedra was 35 years old and 18 weeks pregnant with her second child when she fainted at the doctor’s office after receiving the news that she might need to have a hysterectomy to remove her uterus.
Could the time of day impact the effectiveness of COVID-19 treatment?
For months, experts have warned against the use of anti-inflammatory medications, such as ibuprofen, to treat COVID-19 symptoms. But could the timing of when this drug is taken play a role in its effectiveness?
- Young Houston woman recovers from COVID-19 after participation in two UTHealth clinical trials Heba Hajjar, 23, recovered from COVID-19 after participating in two clinical trials through The University of Texas Health Science Center at Houston (UTHealth) while in the intensive care unit (ICU) at Memorial Hermann-Texas Medical Center. She was so weak she couldn’t move or sit up in bed. She was cautiously monitored on oxygen therapy and […]
- Researchers assess whether blood plasma product could reduce hemorrhaging, improve survival rate of trauma patients The early use of a highly concentrated blood plasma called cryoprecipitate that could reduce deaths from hemorrhaging in trauma patients is being studied by researchers at The University of Texas Health Science Center at Houston (UTHealth) as part of an international trial. The UTHealth Center for Translational Injury Research is launching the Houston site of […]
- Team is first in Texas to join NIH-sponsored study investigating efficacy of convalescent plasma for COVID-19 Using a multimillion-dollar grant from the National Institutes of Health, physician-scientists at The University of Texas Health Science Center at Houston (UTHealth) will investigate whether convalescent plasma infusions can prevent the progression of COVID-19 in one of the first randomized clinical trials in the country. As part of the Center for Clinical and Translational Sciences, […]
- Maternal obesity increases risk of potentially deadly hypertensive disorders early in pregnancy Pregnant obese women were more at risk of experiencing early and late-onset hypertensive disorders, and that risk progressively increased in women with higher body mass indexes (BMI), according to a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth). The retrospective cohort study was recently published in Obstetrics Gynecology. […]
- Flu vaccine may reduce risk of Alzheimer’s disease, new study shows People who received at least one flu vaccination were 17% less likely to get Alzheimer’s disease over the course of a lifetime, according to researchers at The University of Texas Health Science Center at Houston (UTHealth). First author Albert Amran, a fourth-year medical student at McGovern Medical School at UTHealth, presented the findings at the […]
- Maternal depression increases odds of depression in offspring, study shows Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%, according to a new study by researchers at The University of Texas Health Science Center at Houston (UTHealth). The systematic review was recently published in JAMA Network Open. It is the first study to examine […]
- COVID-19 patient at LBJ Hospital recovers after convalescent plasma transfusion More than a month after her battle with COVID-19, Kony Chacon enjoys spending time with newborn daughter and shows no ill effects from the virus that jeopardized her life and that of her unborn child. She credits a century-old treatment now being used to help coronavirus patients fight off the infection – convalescent blood plasma […]
- Researchers study whether vadadustat, an investigational therapy, could mitigate acute lung injury in COVID-19 patients Physicians are studying whether vadadustat, an investigational therapy, could protect the lungs of COVID-19 patients by triggering the body’s protective response to low oxygen levels in a randomized Phase II clinical trial at The University of Texas Health Science Center at Houston (UTHealth). Vadadustat is designed to mimic the physiologic response to hypoxia (low oxygen). […]
- UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann – Texas Medical Center and Harris Health System’s Lyndon B. Johnson Hospital. The […]
- Simple blood test can predict severity of COVID-19 for some patients An early prognosis factor that could be a key to determining who will suffer greater effects from COVID-19, and help clinicians better prepare for these patients, may have been uncovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). Results of the findings were published today in the International Journal of […]
- Team is first in Texas to investigate convalescent plasma for prevention of COVID-19 onset and progression A research team is the first in Texas to investigate whether plasma from COVID-19 survivors can be used in outpatient settings to prevent the onset and progression of the virus in two new clinical trials at The University of Texas Health Science Center at Houston (UTHealth). Convalescent Plasma to Stem Coronavirus will assess whether convalescent […]
- Researchers uncover a critical early step of the visual process The key components of electrical connections between light receptors in the eye and the impact of these connections on the early steps of visual signal processing have been identified for the first time, according to research published today in Science Advances by The University of Texas Health Science Center at Houston (UTHealth). To understand fully […]
- UTHealth joins trial of arthritis drug’s effect on COVID-19-induced cytokine storm A drug is being studied for its effectiveness in treating a type of severe immune overreaction seen in patients with COVID-19-induced pneumonia by researchers at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital. The Phase III, multisite, randomized, double-blind, […]
- Autopsy research aims to advance COVID-19 knowledge In an effort to continue fighting the global COVID-19 pandemic, a team of pathologists from The University of Texas Health Science Center at Houston (UTHealth) has documented the pathological findings from 23 autopsy patients with the disease in an upcoming issue of Cardiovascular Pathology, now available online. The study collated and summarized the findings of autopsy […]
- New study reveals areas of brain where recognition and identification occur Using “sub-millimeter” brain implants, researchers at The University of Texas Health Science Center at Houston (UTHealth), have been able to determine which parts of the brain are linked to facial and scene recognition. The study was published today in Current Biology. “The ability to recognize familiar faces and locations is crucial to everyday life,” said Nitin […]
- New chemotherapy drug studied for malignant brain tumor in children MTX110 is a new formulation of panobinostat, a chemotherapy drug that has shown promise in laboratory models of medulloblastoma, the most common malignant brain tumor in children. Now, MTX110 is the focus of a novel trial that places the therapy directly into the fourth ventricle of the brain to treat patients with recurrent medulloblastoma. According […]
- Scientists and neurosurgeon team up to develop novel imaging device for babies with brain disorders Using night-vision goggle technology, near-infrared light, and high-resolution detectors, a wearable imaging device for awake infants with brain disorders was developed by a team of scientists and a pediatric neurosurgeon at The University of Texas Health Science Center at Houston (UTHealth). Cap-based Transcranial Optical Tomography (CTOT), which utilizes a cap for the baby’s head, is […]
- Experts at UTHealth successfully treat severe case of COVID-19 in 3-week-old infant In one of the first reported cases of its kind, a 3-week-old infant in critical condition recovered from COVID-19 due to rapid recognition and treatment by physicians from McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). The case was published April 22 in the New England Journal of Medicine. […]
- Researchers launch confidential helpline, 833-EMS-INTX, for Texas first responders to find help for substance use disorder First responders in Texas can now call a confidential helpline to seek treatment for substance use and mental health disorders through a new clinical research program at The University of Texas Health Science Center at Houston (UTHealth). The Heroes Helpline comes at a time when first responders are serving on the front lines of the […]
- COVID-19 survivor donates plasma to help others recover from the virus Jose Abdelnoor, 71, and his wife Evelyn Diaz, 67, say they would go through the scary experience of having COVID-19 again if it means they could save a life through donating their antibody-rich plasma. “What greater gift is there to give someone than human life?” Diaz asked. Abdelnoor donated plasma through an experimental therapy program […]